IR Summary







Progen Pharmaceuticals Limited is a publicly listed Australian company. Our listing is on the Australian Securities Exchange (ASX) and the US OTC Market (OTC).



Progen has operations in Australia and the US.







Key Statistics



Ownership: Public



Exchanges: ASX and US OTC Market



Ticker Symbols: ASX: PGL; OTC:PGLA



Exchange Listing Dates: ASX: 1995 OTC:2010







Our Vision



Progen’s vision is two-fold: to improve cancer patients’ lives by providing them with improved oncology solutions; and to create long-term shareholder value through the discovery and development of novel cancer therapeutics.







Investment Highlights



  • Novel anti-cancer portfolio spanning drug discovery and development
  • Strong proprietary position through issued/issuing patents
  • Strong management
  • Strong cash position 
  • Deep discovery and preclinical pipeline